Concepedia

David Eik

DE

3

Publications

73

Citations

3

H-Index

2021

Active since

Affiliations

National Heart Lung and Blood Institute(Current)

National Institutes of Health

Scripps Research Institute

David Eik is an author at National Heart Lung and Blood Institute specializing in tumor immunity, cell biology, and immune regulation.

ORCID

Top concepts

Publications per year

2021–2023

3

Publications

3

Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting

Maissa Mhibik, Erika M. Gaglione, David Eik et al. · Blood Advances · 2023 · 35 citations · Full text

, , +15

BTK inhibitors, irrespective of ITK inhibition, increase efficacy of a CD19/CD3-bispecific antibody in CLL

Maissa Mhibik, Erika M. Gaglione, David Eik et al. · Blood · 2021 · 28 citations · Full text

Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia

Matthew G. Cyr, Maissa Mhibik, Junpeng Qi et al. · Journal for ImmunoTherapy of Cancer · 2022 · 10 citations · Full text

Rows per page

1–3 of 3